Anti-fibrotic therapies target TGF-beta pathways and myofibroblast activity

https://www.instapaper.com/read/2021139836

Anti-fibrotic therapies target TGF-beta pathways and myofibroblast activity, preserving organ function during regeneration and limiting pathological remodeling.